Investors

Cannabis Through Art and Science

Download/Sign up

for Investor Presentation Updates

Adastra Labs & Chemia Analytics

Facility Tour

A look inside one of Canada's largest extraction facilities

At Adastra Labs, our approach is and always has been to develop our processes with efficiency, and end-product quality in mind. Our 13,000 sq ft facility was purpose built, with input from experienced scientists, who have formal education and a passion for the plant. One of our first hires, Donald Dinsmore, Adastra Labs’ QAP, walks you through our facility and gives you a behind-the-scenes look at our Supercritical CO2 process because alongside quality, we believe transparency is key.

Current Market

Stock Symbol: XTRX on CSE

Press Releases

Adastra Closes $3.49 Million Oversubscribed Private Placement

LANGLEY, BC/ ACCESSWIRE / July 14, 2020 / Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) is pleased to announce the closing of its previously announced non-brokered private placement offering (see press releases dated June 18, 2020 and June 25, 2020) issuing 11,648,001 units (the “Units”) for aggregate gross proceeds of $3,494,400.

Read More »

Adastra Increases Private Placement Financing

LANGLEY, BC/  June 25, 2020 / Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing services company announces that it plans to increase its previously announced private placement offering (see press release dated June 18, 2020), of units (the “Units“) at a price of $0.30

Read More »

Adastra Announces Private Placement Financing

June 18, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”, “XTRX”, or the “Company”) a  Health Canada Licensed cannabis processing and analytical testing company announced today that it will be conducting a non-brokered private placement of units (the “Units“) at a price of $0.30 per Unit for gross proceeds of up to $1,000,000 (the “Offering“),

Read More »

Adastra Provides Update On Annual and Interim Financial Statements

May 29, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”), a  Health Canada Licensed cannabis processing and analytical testing services Company, announces, further to Adastra’s April 24, 2020 news release in relation to the timing of the filing of its year-end financial statements, the corporation now expects to file such documents on or prior to June

Read More »

Adastra Announces Initial Distillate Purchase Order from CannMart

May 22nd, 2020 – Adastra Labs Holdings Ltd. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a  Health Canada Licensed cannabis processing and analytical testing services Company, is pleased to announce the receipt of its initial purchase order for bulk distillate from CannMart  Inc. (“CannMart”) a majority owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSX-V: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF). “We are pleased

Read More »

Public Filings

Contact Us

Have a question? Want more information? Looking for a partner to deliver the exceptional service you need for your future business? If you're passionate about cannabis, we'd love to hear from you.

F: 844-874-9893
E: info@adastralabs.ca

5451 275th Street 
Langley, BC, Canada, V4W 3X8

Scroll to Top